These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 23232787)

  • 1. A randomized crossover study comparing the antiplatelet effect of plavix versus generic clopidogrel.
    Sambu N; Radhakrishnan A; Curzen N
    J Cardiovasc Pharmacol; 2012 Dec; 60(6):495-501. PubMed ID: 23232787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized comparison of platelet reactivity in patients after treatment with various commercial clopidogrel preparations: the CLO-CLO trial.
    Oberhänsli M; Lehner C; Puricel S; Lehmann S; Togni M; Stauffer JC; Baeriswyl G; Goy JJ; Cook S
    Arch Cardiovasc Dis; 2012 Nov; 105(11):587-92. PubMed ID: 23177487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of original and generic clopidogrel 600 mg loading dose in the patients who planned undergoing coronary angiography.
    Srimahachota S; Rojnuckarin P; Udayachalerm W; Buddhari W; Chaipromprasit J; Lertsuwunseri V; Akkawat B; Jirapattrathamrong S
    J Med Assoc Thai; 2012 Dec; 95(12):1495-500. PubMed ID: 23390778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the antiplatelet effect of two clopidogrel bisulfate formulations: Plavix and generic-Egitromb.
    Komosa A; Siller-Matula JM; Kowal J; Lesiak M; Siniawski A; Mączyński M; Michalak M; Mularek-Kubzdela T; Grajek S
    Platelets; 2015; 26(1):43-7. PubMed ID: 24499166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioequivalence and tolerability of two clopidogrel salt preparations, besylate and bisulfate: a randomized, open-label, crossover study in healthy Korean male subjects.
    Kim SD; Kang W; Lee HW; Park DJ; Ahn JH; Kim MJ; Kim EY; Kim SW; Nam HS; Na HJ; Yoon YR
    Clin Ther; 2009 Apr; 31(4):793-803. PubMed ID: 19446152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Competency profile of locally manufactured clopidogrel Lowplat and foreign manufactured clopidogrel Plavix in patients of suspected ischemic heart disease (CLAP-IHD).
    Ashraf T; Ahmed M; Talpur MS; Kundi A; Faruqui AM; Jaffery AH; Fareed A
    J Pak Med Assoc; 2005 Oct; 55(10):443-8. PubMed ID: 16304854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of generic clopidogrel bisulfate on platelet inhibition in patients with coronary artery stents: results of the ACCEL-GENERIC study.
    Jeong YH; Koh JS; Kang MK; Ahn YJ; Kim IS; Park Y; Hwang SJ; Kwak CH; Hwang JY
    Korean J Intern Med; 2010 Jun; 25(2):154-61. PubMed ID: 20526388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioequivalence of two tablet formulations of clopidogrel in healthy Argentinian volunteers: a single-dose, randomized-sequence, open-label crossover study.
    Di Girolamo G; Czerniuk P; Bertuola R; Keller GA
    Clin Ther; 2010 Jan; 32(1):161-70. PubMed ID: 20171421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical bioequivalence of a dose of clopidogrel Leti Cravid tablets 75 mg versus clopidogrel Sanofi Plavix tablets 75 mg administered on a daily dose for 7 days on healthy volunteers: a clinical trial.
    Müller A; Octavio J; González MY; Contreras J; Méndez G; Portillo M; Valero Z
    Am J Ther; 2010; 17(3):351-6. PubMed ID: 20019589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clopidogrel (Plavix) and cardiac surgical patients: implications for platelet function monitoring and postoperative bleeding.
    Tanaka KA; Szlam F; Kelly AB; Vega JD; Levy JH
    Platelets; 2004 Aug; 15(5):325-32. PubMed ID: 15370104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Branded versus generic clopidogrel in cardiovascular diseases: a systematic review.
    Caldeira D; Fernandes RM; Costa J; David C; Sampaio C; Ferreira JJ
    J Cardiovasc Pharmacol; 2013 Apr; 61(4):277-82. PubMed ID: 23188124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of tailored loading-dose clopidogrel in patients undergoing selected percutaneous coronary intervention based on adenosine diphosphate-mediated platelet aggregation.
    Meng K; Lü SZ; Zhu HG; Chen X; Ge CJ; Song XT
    Chin Med J (Engl); 2010 Dec; 123(24):3578-82. PubMed ID: 22166634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Switching from generic to brand clopidogrel in male patients after ST-elevated myocardial infarction.
    Syvolap VV; Franskavichene LV; Golukhova EZ; Serebruany VL
    Cardiology; 2014; 129(2):103-5. PubMed ID: 25227134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prasugrel compared with high loading- and maintenance-dose clopidogrel in patients with planned percutaneous coronary intervention: the Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation-Thrombolysis in Myocardial Infarction 44 trial.
    Wiviott SD; Trenk D; Frelinger AL; O'Donoghue M; Neumann FJ; Michelson AD; Angiolillo DJ; Hod H; Montalescot G; Miller DL; Jakubowski JA; Cairns R; Murphy SA; McCabe CH; Antman EM; Braunwald E;
    Circulation; 2007 Dec; 116(25):2923-32. PubMed ID: 18056526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generic Clopidogrel: Has Substitution for Brand Name Plavix® Been Effective?
    Westphal ES; Aladeen T; Vanini D; Rainka M; McCadden K; Gengo FM; Bates V
    J Pharm Pract; 2022 Aug; 35(4):536-540. PubMed ID: 33648379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of clopidogrel and aspirin combination versus aspirin alone on platelet aggregation and major receptor expression in patients with heart failure: the Plavix Use for Treatment Of Congestive Heart Failure (PLUTO-CHF) trial.
    Serebruany VL; Malinin AI; Jerome SD; Lowry DR; Morgan AW; Sane DC; Tanguay JF; Steinhubl SR; O'connor CM
    Am Heart J; 2003 Oct; 146(4):713-20. PubMed ID: 14564328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of collagen versus adenosine diphosphate in detecting antiplatelet effect in patients with coronary artery disease.
    Li J; Jian Z; Huang L; Guo H; Huang J; Qian D; Fu W; Li A; Song Y
    Biomed Pharmacother; 2009 Sep; 63(8):608-12. PubMed ID: 19019624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of association between the 807 C/T polymorphism of glycoprotein Ia gene and post-treatment platelet reactivity after aspirin and clopidogrel in patients with acute coronary syndrome.
    Cuisset T; Frere C; Quilici J; Morange PE; Saut N; Romero-Barra M; Camoin L; Lambert M; Juhan-Vague I; Bonnet JL; Alessi MC
    Thromb Haemost; 2007 Feb; 97(2):212-7. PubMed ID: 17264949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of effects of two different formulations of clopidogrel bisulfate tablets on platelet aggregation and bleeding time in healthy Korean volunteers: A single-dose, randomized, open-label, 1-week, two-period, phase IV crossover study.
    Shim CY; Park S; Song JW; Lee SH; Kim JS; Chung N
    Clin Ther; 2010 Aug; 32(9):1664-73. PubMed ID: 20974324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
    Serebruany VL; Malinin AI; Pokov AN; Hanley DF
    Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.